Back
Catalyst Pharmaceuticals Vs. ADMA Biologics Industry Stock Comparison
Sell
48
CPRX
Catalyst Pharmaceuticals
Last Price:
21.91
Seasonality Move:
1.7%
Buy
72
ADMA
ADMA Biologics
Last Price:
21.81
Seasonality Move:
2.51%
Sell
48
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $21.19. The Score for CPRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy, Sell or Hold?
- The current ADMA Biologics [ADMA] share price is $21.47. The Score for ADMA is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- ADMA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $21.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.
ADMA Stock Price Chart
What is ADMA Biologics's stock price today?
-
The ADMA Biologics share price today is $21.47
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADMA is experiencing slight buying pressure.
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 46.25 | Sell |
| Chaikin Money Flow: | -786667 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.05 - 22.71) | Sell |
| Bollinger Bands (100): | (17.71 - 21.73) | Buy |
ADMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.87 | Buy |
| Relative Strength Index (14 RSI): | 61.01 | Buy |
| Chaikin Money Flow: | 275616 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.89 - 21.45) | Buy |
| Bollinger Bands (100): | (13.94 - 19.98) | Buy |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.18 | Buy |
| 20-day SMA: | 21.97 | Sell |
| 50-day SMA: | 21.13 | Buy |
| 200-day SMA: | 17.61 | Buy |
| 8-day EMA: | 21.43 | Sell |
| 20-day EMA: | 21.62 | Sell |
| 50-day EMA: | 21.07 | Buy |
| 200-day EMA: | 18.28 | Buy |
ADMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.59 | Buy |
| 20-day SMA: | 19.99 | Buy |
| 50-day SMA: | 18.96 | Buy |
| 200-day SMA: | 12.28 | Buy |
| 8-day EMA: | 20.93 | Buy |
| 20-day EMA: | 20.09 | Buy |
| 50-day EMA: | 18.79 | Buy |
| 200-day EMA: | 13.57 | Buy |
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.
ADMA Biologics Earnings Growth & ADMA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.22 per share.
Catalyst Pharmaceuticals Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ADMA Biologics Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||